Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes

NCT02653599 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy

NCT02292433 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

NCT01665352 ·Status: COMPLETED ·Phase: PHASE2

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT01733758 ·Status: COMPLETED ·Phase: PHASE3

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes

NCT02750410 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

NCT00482950 ·Status: UNKNOWN ·Phase: PHASE2

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin

NCT02053103 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.

NCT00759720 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy of Albiglutide in Type 2 Diabetes

NCT00849056 ·Status: COMPLETED ·Phase: PHASE3

Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

NCT00530309 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes

NCT01023581 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes

NCT00924053 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus

NCT01028963 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus

NCT04552470 ·Status: COMPLETED ·Phase: PHASE1

A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

NCT03861039 ·Status: COMPLETED ·Phase: PHASE3

Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects

NCT01755442 ·Status: TERMINATED ·Phase: PHASE1

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

NCT06567041 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone

NCT00402909 ·Status: COMPLETED ·Phase: PHASE4

MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).

NCT00754130 ·Status: COMPLETED ·Phase: PHASE1

Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

NCT02229240 ·Status: WITHDRAWN ·Phase: PHASE3

Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

NCT00495014 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

NCT01468181 ·Status: COMPLETED ·Phase: PHASE3

Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With Metformin

NCT02135549 ·Status: COMPLETED ·Phase: NA

Study In People With Type 2 Diabetes

NCT00196989 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

NCT00850239 ·Status: TERMINATED ·Phase: PHASE3